Contemporary cryptic sexuality in Trypanosoma cruzi

JUAN DAVID RAMÍREZ , FELIPE GUHL , LOUISA A. MESSENGER , MICHAEL D. LEWIS
Molecular Ecology 21 ( 17) 4216 -4226

78
2012
Reduction in mobility and COVID-19 transmission.

Lorenzo Cattarino , Margarita Pons-Salort , Pierre Nouvellet , Pierre Nouvellet
Nature Communications 12 ( 1) 1090 -1090

378
2021
The importance of local context in COVID-19 models

Rosalind M Eggo , Jeanette Dawa , Adam J Kucharski , Zulma M Cucunuba
Nature Computational Science 1 ( 1) 6 -8

5
2021
Impact of contact tracing on COVID-19 mortality: An impact evaluation using surveillance data from Colombia.

Zulma M. Cucunuba , Zulma M. Cucunuba , Andres I. Vecino-Ortiz , Juliana Villanueva Congote
PLOS ONE 16 ( 3)

2
2021
Database of epidemic trends and control measures during the first wave of COVID-19 in mainland China.

Han Fu , Haowei Wang , Xiaoyue Xi , Adhiratha Boonyasiri
International Journal of Infectious Diseases 102 463 -471

1
2021
First report of human Trypanosoma cruzi infection attributed to TcBat genotype.

J. D. Ramírez , C. Hernández , M. Montilla , P. Zambrano
Zoonoses and Public Health 61 ( 7) 477 -479

37
2014
Chagas disease and its oral transmission in Colombia: chronicles of an epidemia. Description of eight outbreaks (2008-2010)

LE Echeverria , EU Suarez , P Zambrano , ZM Cucunuba
European Journal of Heart Failure 16 36 -37

2
2014
Reduction in mobility and COVID-19 transmission. Nat. Commun. 12, 1090

P Nouvellet , S Bhatia , A Cori , KEC Ainslie

13
2021
Proliferative dysfunction in chronically activated T lymphocytes from chagasic patients (70.1)

Nicolas Giraldo , Natalia Bolaños , Adriana Cuellar , Nubia Roa
The Journal of Immunology 188 ( 1_Supplement) 70.1 -70.1

2012
Genetic evidence for the association between COVID-19 epidemic severity and timing of non-pharmaceutical interventions.

Igor Siveroni , Elita Jauneikaite , Erik Volz , Christl A Donnelly
Nature Communications 12 ( 1) 2188 -2188

26
2021
Modelling historical changes in the force-of-infection of Chagas disease to inform control and elimination programmes: application in Colombia

Zulma M Cucunubá , Pierre Nouvellet , Lesong Conteh , Mauricio Javier Vera
BMJ Global Health 2 ( 3)

15
2017
Estimating the health impact of vaccination against 10 pathogens in 98 low and middle income countries from 2000 to 2030

Xiang Li , Christinah Mukandavire , Zulma M Cucunubá , Kaja Abbas
medRxiv 19004358

12
2019
Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients

Ivonne D Flechas , Adriana Cuellar , Zulma M Cucunubá , Fernando Rosas
BMC Infectious Diseases 9 ( 1) 186 -186

42
2009
Complementary paths to Chagas disease elimination: the impact of combining vector control with etiological treatment

Zulma M Cucunubá , Pierre Nouvellet , Jennifer K Peterson , Sarah M Bartsch
Clinical Infectious Diseases 66

11
2018
Estimating the COVID-19 infection fatality ratio accounting for seroreversion using statistical modelling

Nicholas F Brazeau , Robert Verity , Sara Jenks , Han Fu
Communications medicine 2 ( 1) 54

8
2022